Intraperitoneal chemotherapy Journal Article


Author: Schneider, J. G.
Article Title: Intraperitoneal chemotherapy
Abstract: Despite high initial tumor response rates to systemically administered platinum-based chemotherapy, fewer than one quarter of advanced-stage ovarian cancer patients currently experience prolonged disease-free survival. Because persistent and relapsed disease tends to remain confined to the peritoneal cavity, the strategy of enhancing drug delivery to tumor via the direct intraperitoneal route has been the subject of much preclinical and clinical research. This review summarizes the pharmacokinetic rationale, logistical feasibility, and clinical experience associated with intraperitoneal chemotherapy for ovarian cancer.
Keywords: cancer chemotherapy; cancer survival; clinical trial; review; cisplatin; fluorouracil; antineoplastic agents; paclitaxel; chemotherapy, adjuvant; cytarabine; methotrexate; antineoplastic agent; ovarian neoplasms; carboplatin; ovary cancer; pharmacodynamics; etoposide; cyclophosphamide; folinic acid; mitoxantrone; catheterization; tioguanine; streptozocin; intraperitoneal drug administration; injections, intraperitoneal; human; female; priority journal
Journal Title: Obstetrics and Gynecology Clinics of North America
Volume: 21
Issue: 1
ISSN: 0889-8545
Publisher: W.B. Saunders Co.  
Date Published: 1994-03-01
Start Page: 195
End Page: 212
Language: English
PUBMED: 8015764
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Citation Impact
MSK Authors